quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:38:58·43d
ANALYSTRating
Medline Inc. logo

Citigroup resumed coverage on Medline with a new price target

MDLN· Medline Inc.
Health Care
Original source

Companies

  • MDLN
    Medline Inc.
    Health Care

Recent analyst ratings

  • Mar 11UpdateCitigroup$60.00
  • Feb 5UpdateTigress Financial$55.00
  • Jan 21UpdateBTIG Research$55.00
  • Jan 12UpdateCitigroup$48.00
  • Jan 12UpdateBNP Paribas Exane$38.00
  • Jan 12UpdateAnalyst$50.00

Related

  • SEC23h
    SEC Form DEFA14A filed by Medline Inc.
  • SEC23h
    SEC Form DEF 14A filed by Medline Inc.
  • PR7d
    Medline announces first-in-healthcare AI robotics partnership with Symbotic
  • PR15d
    Medline to report first quarter 2026 results on May 6, 2026
  • PR17d
    Medline launches custom product fulfillment technology called Pick Pack Pro™
  • PR20d
    Medline recognizes manufacturing facilities with Golden Cone Safety Award
  • PR22d
    Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
  • INSIDER42d
    Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022